Greek pharma faces new crunch moment
This article was originally published in Scrip
Executive Summary
A new draft law is looming in Greece which will have far-reaching implications for the pharmaceutical industry. As the various stakeholders haggle over the 2014 medicines budget – and industry warns that a threatened cut of more than 15% to the outpatient drugs bill could spell catastrophe for public health – the health ministry is preparing a draft law on pricing, reimbursement and other issues relevant to the pharma sector that is expected before the end of the month.